NCT02455193

Brief Summary

This study plans to learn more about how common drugs prescribed to individuals with schizophrenia contribute to weight gain, as well as how exercise and diet impact appetite and the brain's response to food. In this study, the investigators will be evaluating how participants' brains respond to food images as well as asking questions about their food preferences and intake and clinical symptoms. The investigators may also ask participants to complete an exercise or diet intervention to see how this changes brain responses or food preferences.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 27, 2015

Completed
10.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

April 22, 2025

Status Verified

April 1, 2025

Enrollment Period

11.1 years

First QC Date

May 21, 2015

Last Update Submit

April 21, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Neuronal response to visual food cues

    Neuronal response (insula) while viewing visual food cues

    14 weeks

  • Resting-state neuronal response

    Neuronal response (default mode network) during rest

    14 weeks

Secondary Outcomes (3)

  • Appetite Rating on a visual analogue scale (VAS)

    14 weeks

  • Fasting leptin

    14 weeks

  • Fasting ghrelin

    14 weeks

Study Arms (2)

Exercise intervention

EXPERIMENTAL

10 weeks of a moderate exercise intervention

Behavioral: Exercise

Diet intervention

ACTIVE COMPARATOR

10 weeks of a diet intervention

Behavioral: Diet

Interventions

ExerciseBEHAVIORAL
Exercise intervention
DietBEHAVIORAL
Diet intervention

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of schizophrenia or schizoaffective disorder
  • Between 21 and 70 years of age
  • Currently prescribed either olanzapine, risperidone, clozapine, or haloperidol, OR not currently being treated with any neuroleptic medications
  • Weight stable within 5 percent for the last 6 months

You may not qualify if:

  • Pregnancy
  • Substance abuse
  • Significant endocrine/metabolic disease (e.g., uncontrolled hypertension, severe hypertriglyceridemia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States

RECRUITING

MeSH Terms

Conditions

Schizophrenia

Interventions

ExerciseDiet

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Jason Tregellas, Ph.D.

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kristina T Legget, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2015

First Posted

May 27, 2015

Study Start

August 1, 2014

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

April 22, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations